Governance 3SBio Inc.

1530

KYG8875G1029

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 08:08:04 06/02/2026 GMT			5-day change	1st Jan Change
22.94 ^HKD	-0.78%		-1.55%	-5.13%

12-02	3SBio Seeks HK$3.12 Billion via Share Sale	MT
12-02	3SBio to place 105.2 million shares	RE

Executive Committee: 3SBio Inc.

Manager

Positions heldSince

Jing Lou

63 year

Chief Executive Officer	31/12/2005
Founder	31/12/1992
President	31/12/1992

Xin Ma

60 year

Human Resources Officer

Siu Kuen Lai

50 year

Corporate Secretary

09/02/2022

Xiang He

Director of Finance/CFO

02/07/2023

Composition of the Board of Directors: 3SBio Inc.

Director

CommitteesSince

Jing Lou

63 year

Nominating Committee Chair	09/05/2013
Nominating Committee

Hoi Ti Yang

56 year

Audit Committee
Nominating Committee	24/06/2025
Compensation Committee Chair	20/01/2022
Compensation Committee
Nominating Committee Chair

Tian Ruo Pu

57 year

Audit Committee Chair	02/10/2022
Compensation Committee Chair	31/05/2015
Governance Committee	02/10/2022
Nominating Committee	02/10/2022
Compensation Committee	02/10/2022

Joo Yeow Ng

61 year

Audit Committee	20/01/2022
Compensation Committee	24/06/2024
Nominating Committee	20/01/2022

Dong Mei Su

56 year

Audit Committee

08/09/2022

Jiaoe Zhang

63 year

Director/Board Member

24/06/2024

Latest Appointments: 3SBio Inc.

25/06/25	3SBio Inc. Announces Changes in Composition of the Nomination Committee, with Effect from 25 June 2025	CI
25/06/24	3Sbio Inc. Announces Board Changes	CI
22/04/24	3Sbio Inc. Announces Board and Committee Changes	CI
04/01/24	Venus Medtech Names Former 3SBio Finance Chief as CFO	MT
31/07/23	3SBio Hires Former JPMorgan Exec as CFO	MT
03/01/23	3SBio Inc. Announces Resignation of Tang Ke as Non-Executive Director	CI
30/12/22	3Sbio Inc. Announces Executive Changes	CI

More news

Former Officers and Directors: 3SBio Inc.

Insider

Positions held

SinceUntil

Bin Huang

Director/Board Member	31/12/2005	24/06/2024
Corporate Officer/Principal	31/12/1992	19/06/2019

Dan Zhang

Director/Board Member	29/12/2022	24/06/2024
Independent Dir/Board Member	29/12/2022	24/06/2024

Fei Wang

Director of Finance/CFO

14/04/2020

02/07/2023

Ke Tang

Director/Board Member

09/02/2020

29/12/2022

Kwok Fai Lee

Corporate Secretary

16/07/2021

09/02/2022

Lap Yan Wong

Director/Board Member	07/10/2019	20/01/2022
Independent Dir/Board Member	07/10/2019	20/01/2022

Suet Wing Leung

Corporate Secretary

19/08/2018

16/07/2021

David Parkinson

Director/Board Member	26/11/2014	28/06/2021
Independent Dir/Board Member	26/11/2014	28/06/2021

Dong Liu

Director/Board Member

26/11/2014

09/02/2020

Bo Tan

Director/Board Member	31/01/2009	30/11/2019
Director of Finance/CFO	31/01/2009	30/11/2019

Rui Wang

Director/Board Member	19/06/2019	07/10/2019
Independent Dir/Board Member	19/06/2019	07/10/2019

Yan Li Liu

Corporate Secretary

28/04/2016

07/10/2019

Da Song Wang

Director/Board Member

29/06/2017

07/10/2019

Zhen Ping Zhu

Chief Tech/Sci/R&D Officer

08/01/2017

31/08/2019

Wei Hong Xiao

Chief Operating Officer

03/03/2016

31/08/2019

Jun Ma

Director/Board Member	26/11/2014	19/06/2019
Independent Dir/Board Member	26/11/2014	19/06/2019

Thomas Folinsbee

Corporate Officer/Principal

31/12/2008

31/12/2018

Fei You

Corporate Officer/Principal

31/01/2011

31/08/2018

Dong Lü

Director/Board Member

26/11/2014

29/06/2017

Min Jia

Corporate Officer/Principal

31/07/2013

28/02/2017

Hui Hui Li

Corporate Secretary

31/08/2013

28/04/2016

Dan Lou

Chairman	31/12/2002	31/03/2012
Founder	31/12/1992	31/03/2012

Zhonghua Zhang

Human Resources Officer

31/07/2011

David Chen

Chief Operating Officer

29/06/2011

Liping Xu

Corporate Officer/Principal

09/03/2010

Pei Guo Cong

Director/Board Member	10/03/2010	-
Independent Dir/Board Member	17/10/2011	-

Guanjin Hu

Director/Board Member

14/02/2008

Ming De Yu

Director/Board Member	14/02/2008	-
Independent Dir/Board Member	17/10/2011	-

Clara Mak

Director of Finance/CFO

27/01/2008

Lawrence S. Wizel

Director/Board Member	31/08/2006	-
Independent Dir/Board Member	17/10/2011	-

Ying Fei Wei

Chief Tech/Sci/R&D Officer	25/10/2011	-
Corporate Officer/Principal	17/10/2011	25/10/2011

Mou Jia Qi

Director/Board Member	31/07/2006	-
Independent Dir/Board Member	30/08/2011	-

Hui Dang

Director/Board Member	31/07/1999	-
Compliance Officer	31/07/1999	-

Ke Li

Corporate Officer/Principal

31/12/1992

Ming Yu Zhang

Corporate Officer/Principal

17/10/2011

Wei Cao

Corporate Officer/Principal

17/10/2011

Hui Zhang

Public Communications Contact

Cui Ping Gu

Director/Board Member

Mingming Yan

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	8
Female	3

Of which Executive Committee

Male	3
Female	1

Of which Directors

Male	4
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

3SBio Inc is an investment holding company mainly engaged in the development, production, marketing and sale of pharmaceutical products. The Companyâ€™s core products include several biopharmaceutical drugs, TPIAO, recombinant human erythropoietin(rhEPO) products, with brand of EPIAO and SEPO, Yisaipu, Cipterbin and a small molecule drug, Mandi and tumor necrosis factor (TNF). Through its subsidiaries, the Company is engaged in project management and consultation. The Company still engages in developing innovative biological products, including mAbs, bi-specific antibodies and fusion proteins, and a number of small molecule drugs, both innovative and generic, in the areas of nephrology, oncology, auto-immune and inflammatory diseases, ophthalmology and dermatological diseases. The Company distributes its products within the domestic market and to overseas markets.

Employees

6,268

Sector

Pharmaceuticals

Calendar

03-30 - Q4 2025 Earnings Release (Projected)

More about the company